INDIGO
Live / Registered — Registered (as of 11 Oct 2022)
What this means for you
Registered since 11 Oct 2022. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 11 Oct 2028: the §71 affidavit of use).
Record
- Serial number
- 79320764
- Registration number
- 6868385
- Mark type
- Word mark
- Filed
- 06 Apr 2021
- Published for opposition
- 26 Jul 2022
- Registered
- 11 Oct 2022
- Next maintenance filing
- §71 affidavit of use, due by 11 Oct 2028 (grace period to 11 Apr 2029)
- Attorney of record
- Raymond Wagenknecht
Goods and services
- Class 001 — Chemicals: Adsorbent chemical products, namely, agarose resins for protein purification other than for medical or veterinary purposes; All of the aforementioned goods expressly exclude nuclear receptor assays and cell-based reporter systems
- Class 005 — Pharmaceuticals: Reagents for use with analyzers, namely, agarose resins for protein purification for medical and veterinary purposes; All of the aforementioned goods expressly exclude nuclear receptor assays and cell-based reporter systems
Owner
- Cube Biotech GmbH, DE
- Cube Biotech GmbH, DE
- Cube Biotech GmbH, DE
Prosecution history
- 20 Feb 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 31 Jan 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 31 Jan 2023 — FINAL DISPOSITION PROCESSED
- 11 Jan 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 11 Oct 2022 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Oct 2022 — REGISTERED-PRINCIPAL REGISTER
- 26 Jul 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Jul 2022 — PUBLISHED FOR OPPOSITION
- 25 Jul 2022 — NOTIFICATION PROCESSED BY IB
- 06 Jul 2022 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
- 06 Jul 2022 — NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
- 06 Jul 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Jun 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 17 Jun 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jun 2022 — CORRESPONDENCE RECEIVED IN LAW OFFICE